Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE

Slides:

Advertisements

Similar presentations

Description of Each Study in the Cross Trial Safety Analysis Solomon SD, et al. Circulation 2008 [Epub Mar 31]

Advertisements

CaD TrialObservational Study All participantsNo Personal Supplements a Non-users ofCalcium +CalciumVitamin D PlaceboCaDPlaceboCaDSupplementsVitamin DOnly.

Hazard of incident coronary heart disease by diabetes status, with or without elevation of troponin T No diabetes Pre- diabetes Diabetes No diabetes Pre-

Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Vitamin D and Cardiovascular Disease: Will It Live.

Date of download: 5/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Omega-3 Polyunsaturated Fatty Acids and Cardiovascular.

Date of download: 5/31/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Estrogen Plus Progestin and Breast Cancer Incidence.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.

Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Habitual Coffee Consumption on Cardiometabolic.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Date of download: 6/30/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Cardiorespiratory Fitness as a Quantitative Predictor.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: Procedural Outcomes of Chronic Total Occlusion Percutaneous.

Date of download: 7/9/2016 Copyright © The American College of Cardiology. All rights reserved. From: Making Sense of Statistics in Clinical Trial Reports:

Date of download: 7/10/2016 Copyright © The American College of Cardiology. All rights reserved. From: Healthy Lifestyle and Decreasing Risk of Heart Failure.

Search strategy and results Amir Kashani, et al. Circulation. 2006;114:

Date of download: 11/12/2016 Copyright © The American College of Cardiology. All rights reserved. From: Asymptomatic Individuals With a Positive Family.

CHA2DS2-VASC and CHADS2 Scores Predict Adverse Clinical Events in Patients With Pacemakers and Sinus Node Dysfunction Independent of Atrial Fibrillation

The SPRINT Research Group

Copyright © 2003 American Medical Association. All rights reserved.

Copyright © 2004 American Medical Association. All rights reserved.

Copyright © 2012 American Medical Association. All rights reserved.

Associations of renal impairment (adjusted odds ratio and 95% CI) and the presence of individual small vessel disease markers stratified by age. Associations.

Circ Cardiovasc Qual Outcomes

Atrial Fibrillation and Mortality in Heart FailureClinical Perspective

by Alexander Kulik, Ian G. Burwash, Varun Kapila, Thierry G

Association of Lipids With Incident Heart Failure Among Adults With and Without Diabetes MellitusClinical Perspective by Imo A. Ebong, David C. Goff, Carlos.

Prehypertension, Diabetes, and Cardiovascular Disease Risk in a Population-Based Sample by Ying Zhang, Elisa T. Lee, Richard B. Devereux, Jeunliang Yeh,

Sex-Related Differences in Fractional Flow Reserve–Guided Treatment

Circ Cardiovasc Interv

Plasma Vitamin C, but Not Vitamin E, Is Associated With Reduced Risk of Heart Failure in Older MenClinical Perspective by Sasiwarang Goya Wannamethee,

Association of Rare Loss-Of-Function Alleles in HAL, Serum HistidineCLINICAL PERSPECTIVE by Bing Yu, Alexander H. Li, Donna Muzny, Narayanan Veeraraghavan,

Circ Cardiovasc Interv

Site Selection and Performance in Clinical Trials

Plasma Free Fatty Acids and Risk of Heart FailureClinical Perspective

Ahead of the Curve by Alun D. Hughes Hypertension Volume 64(5):

Circ Cardiovasc Qual Outcomes

Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart FailureClinical Perspective by A. Rogier van der Velde, Lars Gullestad,

Arterial Stiffness, Central Pressures, and Incident Hospitalized Heart Failure in the Chronic Renal Insufficiency Cohort StudyCLINICAL PERSPECTIVE by Julio.

Effects of Mineralocorticoid Receptor Antagonists on the Risk of Sudden Cardiac Death in Patients With Left Ventricular Systolic DysfunctionClinical Perspective.

Hazard ratio (HR) for mortality for a 1-kg/m2 increase in body mass index (BMI) across the range of baseline BMI among patients with acute ischemic stroke.

Body Mass Index and Heart Failure Among Patients With Type 2 Diabetes MellitusCLINICAL PERSPECTIVE by Weiqin Li, Peter T. Katzmarzyk, Ronald Horswell,

Circ Cardiovasc Interv

Pulse Pressure and Resistance Artery Structure in the Elderly

Masaya Koshizaka, MD, PhD, Renato D. Lopes, MD, PhD, MHS, L

Prevalence, Predictors, and Outcomes in Treatment-resistant Hypertension in Patients with Coronary Disease Sripal Bangalore, MD, MHA, Rana Fayyad, PhD,

Risk of ESRD and Mortality in Kidney and Bladder Stone Formers

Impact of Electronic Acute Kidney Injury (AKI) Alerts With Automated Nephrologist Consultation on Detection and Severity of AKI: A Quality Improvement.

Fung TT, et al. Circulation 2009;119:

Volume 88, Issue 2, Pages (August 2015)

David J.A. Jenkins et al. JACC 2018;71:

Yousef Rezaei, MD American Journal of Kidney Diseases

Baseline Characteristics

Kaplan–Meier estimates of the incidence of first heart failure hospitalization during follow-up according to the statin category among patients with type.

Flow diagram for exclusions of trials identified RCT indicates randomized controlled trial Hulten E, et al. Arch Intern Med 2006;166:

Christina L. Klein, MD, Daniel C. Brennan, MD, FACP

Impact of Diabetes Mellitus on the Association of Vascular Disease Before Transplantation With Long-term Transplant and Patient Outcomes After Kidney.

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Kaplan-Meier plots of hHF: DPP-4i and SU cohort with baseline CVD (panel A); saxagliptin and sitagliptin cohorts with baseline CVD (panel B); DPP-4i and.

Baseline Characteristics by hs-CRP

Risk of having any adverse effects with supplements compared with placebo. Risk of having any adverse effects with supplements compared with placebo. Stratified.

Forest plot showing the association between center-level characteristics and death-censored technique failure after adjusting for age, sex, race, body.

Flow chart of search strategy

Kaplan–Meier plots of 5 and 12-year all cause (A and C, respectively) and cardiovascular mortality (B and D, respectively) with number of participants.

T2DM patients with HF may benefit from SGLT2 inhibitor therapy

Associations between type of MI and incident HF

Increase of physical activity over time associated with lower HF risk

Risk differences for incident stroke, coronary heart disease (CHD), and cardiovascular mortality (per 1000 person-years) by clinical risk factor in the.

A: Forest plot of the HR of AE of bone fracture between the saxagliptin and placebo groups across subgroups by demographic and medical history parameters.

Subgroup analysis of associations between egg consumption and risk of incident cardiovascular disease (CVD), ischaemic heart disease (IHD), haemorrhagic.

Subgroup analysis of associations between daily tea consumption and risk of ischaemic heart disease (IHD) according to potential baseline risk factors.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Risk of Heart Failure Among Postmenopausal WomenCLINICAL PERSPECTIVE by Macarius M. Donneyong, Carlton A. Hornung, Kira C. Taylor, Richard N. Baumgartner, John A. Myers, Charles B. Eaton, Eiran Z. Gorodeski, Liviu Klein, Lisa W. Martin, James M. Shikany, Yiqing Song, Wenjun Li, and JoAnn E. Manson Circ Heart Fail Volume 8(1):49-56 January 20, 2015 Copyright © American Heart Association, Inc. All rights reserved.

Participant recruitment and selection for the vitamin D plus calcium (CaD) trial and analyses. Participant recruitment and selection for the vitamin D plus calcium (CaD) trial and analyses. DM indicates diabetes mellitus; and HT, hypertension. Macarius M. Donneyong et al. Circ Heart Fail. 2015;8:49-56 Copyright © American Heart Association, Inc. All rights reserved.

Kaplan–Meier curves comparing the cumulative incidence of heart failure between the vitamin D plus calcium (CaD) and placebo arms during follow-up period in the overall CaD cohort (A) and stratified baseline subgroups (B). Kaplan–Meier curves comparing the cumulative incidence of heart failure between the vitamin D plus calcium (CaD) and placebo arms during follow-up period in the overall CaD cohort (A) and stratified baseline subgroups (B). CI indicates confidence interval; and HR, hazard ratio. Macarius M. Donneyong et al. Circ Heart Fail. 2015;8:49-56 Copyright © American Heart Association, Inc. All rights reserved.

Forest plot of hazard ratios for effect of vitamin D plus calcium (CaD) supplementation on heart failure (HF). Forest plot of hazard ratios for effect of vitamin D plus calcium (CaD) supplementation on heart failure (HF). CHD indicates coronary heart disease; CI, confidence interval; and CVD, cardiovascular diseases. Macarius M. Donneyong et al. Circ Heart Fail. 2015;8:49-56 Copyright © American Heart Association, Inc. All rights reserved.